43
Views
7
CrossRef citations to date
0
Altmetric
Original Article

The Secretion of Endothelin-1 by Microvascular Endothelial Cells from Human Benign Prostatic Hyperplasia is Inhibited by Vascular Endothelial Growth Factor

, , , , &
Pages 281-289 | Received 05 Dec 2003, Published online: 07 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Xi Zhang, Yongjie Shao & Kunjie Wang. (2016) Incidence and risk of hypertension associated with cabozantinib in cancer patients: a systematic review and meta-analysis. Expert Review of Clinical Pharmacology 9:8, pages 1109-1115.
Read now
Benoit Blanchet, Bertrand Billemont, Stéphane Barete, Hélène Garrigue, Laure Cabanes, Romain Coriat, Camille Francès, Bertrand Knebelmann & François Goldwasser. (2010) Toxicity of sorafenib: clinical and molecular aspects. Expert Opinion on Drug Safety 9:2, pages 275-287.
Read now
Axel Stachon, Assem Aweimer, Tanja Stachon, Andrea Tannapfel, Sven Thoms, Burkhard Ubrig, Manfred Köller, Michael Krieg & Michael C. Truss. (2009) Secretion of soluble VEGF receptor 2 by microvascular endothelial cells derived by human benign prostatic hyperplasia. Growth Factors 27:2, pages 71-78.
Read now
Angelo J Cambio & Christopher P Evans. (2007) Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH). Therapeutics and Clinical Risk Management 3:1, pages 181-196.
Read now

Articles from other publishers (3)

A Aweimer, T Stachon, A Tannapfel, M Köller, M C Truss & A Stachon. (2011) Regulation of soluble VEGFR-2 secreted by microvascular endothelial cells derived from human BPH. Prostate Cancer and Prostatic Diseases 15:2, pages 157-164.
Crossref
M. Sitki Copur & Angela Obermiller. (2011) An Algorithm for the Management of Hypertension in the Setting of Vascular Endothelial Growth Factor Signaling Inhibition. Clinical Colorectal Cancer 10:3, pages 151-156.
Crossref
Marlies H.G. LangenbergCarla M.L. van HerpenJohann De BonoJan H.M. SchellensClemens UngerKlaas HoekmanHubert E. BlumWalter FiedlerJoachim DrevsFlorence Le MaulfAnitra FieldingJane RobertsonEmile E. Voest. (2009) Effective Strategies for Management of Hypertension After Vascular Endothelial Growth Factor Signaling Inhibition Therapy: Results From a Phase II Randomized, Factorial, Double-Blind Study of Cediranib in Patients With Advanced Solid Tumors. Journal of Clinical Oncology 27:36, pages 6152-6159.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.